Immunoassay Market Players:
- Abbott
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Beckman Coulter, Inc.
- QuidelOrtho Corporation
- Bio-Rad Laboratories, Inc.
- Becton, Dickinson, and Company
- BIOMÉRIEUX
- F. Hoffmann-La Roche AG
- Thermo Fisher Scientific, Inc.
- Siemens Healthinners AG
- Merck KGaA
- Hologic, Inc.
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- MIZUHO MEDY Co., Ltd.
- Immunosens Co., Ltd.
- Immuno-Biological Laboratories Co, Ltd.
- H.U. Group Holdings, Inc.
- Sysmex Corporation
- Sumitomo Bakelite Co., Ltd.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of immunoassay is estimated at USD 34.84 billion.
The global immunoassay market size was more than USD 33.31 billion in 2025 and is anticipated to witness a CAGR of over 5.1%, crossing USD 54.78 billion revenue by 2035.
North America immunoassay market will secure over 41% share by 2035, driven by growing healthcare investment and advanced technologies.
Key players in the market include Abbott, Beckman Coulter, Inc., QuidelOrtho Corporation, Bio-Rad Laboratories, Inc., Becton, Dickinson, and Company, BIOMÉRIEUX, F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Inc., Siemens Healthinners AG, Merck KGaA, Hologic, Inc., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., MIZUHO MEDY Co., Ltd., Immunosens Co., Ltd., Immuno-Biological Laboratories Co, Ltd., H.U. Group Holdings, Inc., Sysmex Corporation, Sumitomo Bakelite Co., Ltd.
